- Home
- PGEN vs DSM Comparison
PGEN vs DSM Comparison
Compare PGEN & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- DSM
- Stock Information
- Founded
- PGEN 1998
- DSM 1989
- Country
- PGEN United States
- DSM United States
- Employees
- PGEN N/A
- DSM N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- DSM Investment Managers
- Sector
- PGEN Health Care
- DSM Finance
- Exchange
- PGEN Nasdaq
- DSM Nasdaq
- Market Cap
- PGEN 292.6M
- DSM 303.5M
- IPO Year
- PGEN N/A
- DSM N/A
- Fundamental
- Price
- PGEN $0.77
- DSM $6.12
- Analyst Decision
- PGEN Buy
- DSM
- Analyst Count
- PGEN 5
- DSM 0
- Target Price
- PGEN $7.00
- DSM N/A
- AVG Volume (30 Days)
- PGEN 943.5K
- DSM 161.7K
- Earning Date
- PGEN 11-14-2024
- DSM 01-01-0001
- Dividend Yield
- PGEN N/A
- DSM 3.97%
- EPS Growth
- PGEN N/A
- DSM N/A
- EPS
- PGEN N/A
- DSM N/A
- Revenue
- PGEN $3,963,000.00
- DSM N/A
- Revenue This Year
- PGEN N/A
- DSM N/A
- Revenue Next Year
- PGEN $426.76
- DSM N/A
- P/E Ratio
- PGEN N/A
- DSM N/A
- Revenue Growth
- PGEN N/A
- DSM N/A
- 52 Week Low
- PGEN $0.76
- DSM $4.69
- 52 Week High
- PGEN $1.93
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- PGEN 38.75
- DSM 54.98
- Support Level
- PGEN $0.84
- DSM $6.09
- Resistance Level
- PGEN $0.97
- DSM $6.18
- Average True Range (ATR)
- PGEN 0.07
- DSM 0.05
- MACD
- PGEN -0.01
- DSM 0.02
- Stochastic Oscillator
- PGEN 5.15
- DSM 71.74
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.